301 Coeliac Disease Flashcards

1
Q

Symptoms of coeliac disease

A

Bloating, diarrhoea, nausea, flatulence, constipation, tiredness, headaches, sudden weight loss, hair loss, anaemia, osteoporosis, rash (dermatitis herpetiformis), neurological disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What can coeliac disease lead to?

A

Kidney & liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mortality rate in untreated coeliac disease

A

Factor 1.9-3.8
Caused by link to malignancies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is gluten?

A

2 proteins: gliadin & glutenin
2 similar proteins in barley (hordeins) and rye (secalins)
10% wheat made up of gluten

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is gluten involved in?

A

Starch storage in cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How much gluten can coeliac suffers tolerate?

A

20ppm so food must contain less than this to be “gluten free”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Coeliac disease immune response to gluten:
Trigger
Immune activation
Antibodies
Result
Treatment

A
  1. Gluten (from wheat, barley, rye) ingested
  2. Modified gluten peptides trigger T cells
  3. B cells produce anti-tTG and anti-gliadin antibodies
  4. Inflammation damages intestinal villi, leading to malabsorption
  5. Lifelong gluten-free diet
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does immune response occur with gluten in coeliac disease?

A

T cells react with gluten peptides, especially gliadin), which has been modified by enzyme tissue transglutaminase (tTG)
B cells produce antibodies against gluten and tTG, resulting in inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Genetic predisposition for coeliac disease and immune response

A

People with genetic predisposition carry HLA-DQ2 or HLA-DQ8 genes which these T cells recognise gluten as a threat, becoming activated and launches immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the mechanism of CD4 T-cell response to gliadin in coeliac disease?

A

Tissue transglutaminase (tTG) deamidates native peptides, creating modified peptides
These presented by DQ2/DQ8 on antigen-presenting cells, activating CD4 T-cells
Activation leads to interferon-γ release causing destructive intestinal lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does gluten trigger the immune response in coeliac disease?

A

Gluten-derived gliadin modified by tTG & presented by HLA-DQ2/8 on antigen-presenting cells
Activates T cells releasing IFNγ and promotes IL-15 expression
IL-15 stimulates NK-like cells to target intestinal cells, causing villi loss, crypt elongation & increased intraepithelial lymphocytes (IELs)
B cells produce antibodies against gliadin, endomysium & tTG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Coeliac sufferers and their genetics

A

All have HLA-DQ2 (90%) or DQ8 genes (10%)
MHC II molecules binds negatively charged peptides
Gluten not negatively charged but can be deamidated by tTG
Gluten is proline rich so not digested well
A deamidated 33mer binds to MHC with high affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diagnosis of coeliac disease

A

Serum analysis for anti-gliadin/tTG antibodies
ELISA
Biopsy of intestine
HLA typing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Therapeutic agent: genetically modified gluten and MOA

A

Decreases gluten exposure by transamidation of gliadin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Therapeutic agent: zonulin inhibitor and MOA

A

Decreases zonulin secretion and inhibits intestinal permeability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Therapeutic agent: therapeutic vaccine and MOA

A

Creates immune tolerance to gluten fragments & desensitises coeliac disease patients to toxic effects of gluten

17
Q

Therapeutic agent: probiotics and MOA

A

Detoxify gliadin & promote intestinal healing

18
Q

Therapeutic agent: tissue transglutaminase inhibitors and MOA

A

Stop tissue transglutaminases from modifying gluten fragments, a process that otherwise triggers immune response

19
Q

Aetiology of coeliac disease

A
  1. Genetics: genetic markers HLA-DQ2/8, 95% of people carry these genes are coeliac
  2. Environmental factors: gluten exposure, infections, early-life GI infections & gut microbiome imbalances
  3. Immune system dysregulation: with genetic predisposition consuming gluten, inflammation trigger
20
Q

Nutritional implications: malabsorption

A

Damage to intestinal villi impairs nutrient absorption
Leads to vitamin deficiencies
Particularly if coeliac is untreated

21
Q

Nutritional implications: vitamin and mineral deficiencies

A
  1. Iron: iron-deficiency anaemia due to impaired absorption which can lead to fatigue & weakness
  2. vit B: folate, B12 & B6 affecting energy levels, nerve function & RBC production
  3. Calcium & vit D: osteoporosis or osteopenia
  4. Zinc and Mg: affecting immune & muscle function
22
Q

Nutritional implications: weight loss or growth issues

A

Children with untreated coeliac may experience stunted growth or delayed therapy
Adults may experience weight loss, weakness or muscle wasting

23
Q

Nutritional implications: fat malabsorption

A

Damage to intestine leads to difficulty absorbing fats
Leads to fat-soluble vitamin deficiencies (A, D, E, K) and symptoms like diarrhoea & steatorrhoea

24
Q

Nutritional implications: increased risk of lactose intolerance

A

Damage to intestinal lining may lead to 2ndary lactose (which digests lactose) is reduced when villi compromised

25
Q

Nutritional implications: risk of additional health conditions

A

Prolonged nutrient deficiencies can increase risk of anaemia, osteoporosis, neurological disorders and fertility issues